Germain Dermatology Adds Image-Guided Superficial Radiotherapy with the SRT-100 Vision™ for Treating Basal and Squamous Cell Carcinoma in Charleston, SC

    NEXT STORY
    Trinity Biotech plc to Announce Second Quarter Fiscal Year 2019 Financial Results
    PREV STORY
    Generex Biotechnology Defines 1:1 Stock Dividend and Provides Details on Capital Structure
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cancer Genetics Announces 1-for-30 Reverse Stock Split

    author_avatar
    NASDAQ Market News

    Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma

    Sanofi and Regeneron Announce That Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer

    COPENHAGEN, Denmark, April 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical ...

    author_avatar
    NASDAQ Market News